Landmark study sheds new light on the heterogeneity of type 2 diabetes

NewsGuard 100/100 Score

A landmark study by the DZD, published in 'The Lancet Diabetes & Endocrinology', sheds new light on the heterogeneity of type 2 diabetes. The researchers employed an innovative algorithm to stratify people with type 2 diabetes using routine data and thus visualize the metabolic diversity of diabetes.

Type 2 diabetes is a disease with highly diverse progression pathways. Using an innovative algorithm, a team led by the German Diabetes Center (DDZ) used routinely measured variables to open up new perspectives on the diversity of type 2 diabetes in terms of insulin sensitivity, insulin secretion, distribution of fatty tissue, and pro-inflammatory profiles.

Algorithm for precision diabetes diagnosis

The work presents a unique, tree-like representation of diabetes heterogeneity that was originally developed by researchers in Great Britain under the leadership of Ewan Pearson and has now been refined with data from the German Diabetes Study (GDS) and the LURIC cohort. This innovative structure makes it possible to show different subtypes of type 2 diabetes in order to more clearly demonstrate how complex this disease is. Lead author Dr. Martin Schön stresses the importance of the study: "Our results demonstrate that we must consider type 2 diabetes in a significantly more differentiated manner and also, therefore, that there should not only be a single treatment for everyone."

Besides age and sex, the algorithm is based on simple routine data that is either available to therapists or can be collected easily, such as BMI, total cholesterol, or HbA1c. In this way, people who produce less insulin or tend to exhibit insufficiently controlled hypertension or lipid metabolism disorders within the first five years of a diabetes diagnosis can be identified early on. Additionally, risks such as premature mortality and specific diabetes complications can also be visualized.

On the way to precision diabetology

In recent years, countless results have been obtained at the DDZ for the purpose of subtyping diabetes mellitus. Continual refinement of these subtypes is now the goal for the precision diabetology of the future, says Prof. Dr. Michael Roden, director of the Clinic for Endocrinology and Diabetology at the University Hospital Düsseldorf and director of the DDZ. "Differentiating between subgroups of diabetes using simple clinical data will rapidly accelerate the development of new approaches to prevention and treatment in order to ultimately identify and treat high-risk groups in a targeted manner," underlines the expert.

Practical application

A simple illustration of the different forms and risks of type 2 diabetes, which can also be discussed with patients, delivers added value in daily practice. "Consequently, these research results could also be incorporated into everyday practice," says Prof. Robert Wagner, who led the study at DDZ and is deputy director of the Clinic for Endocrinology and Diabetology at the University Hospital Düsseldorf.

"The results of the study have the potential to change the way we understand and treat type 2 diabetes. An easy-to-use online tool already exists, making it possible to recognize and understand the biological heterogeneity of type 2 diabetes," states Wagner. It has the potential to serve as a template for the development of more precise therapeutic approaches.

The algorithm clearly visualizes the diversity of type 2 diabetes and the variability of diabetes progression. It can be accessed and used via the following link: https://atn-uod2018.shinyapps.io/Prediction_diabetes_outcome_18082021/

Source:
Journal reference:

Schön, M., et al. (2023). Analysis of type 2 diabetes heterogeneity with a tree-like representation: insights from the prospective German Diabetes Study and the LURIC cohort. The Lancet Diabetes & Endocrinology. doi.org/10.1016/s2213-8587(23)00329-7.

Comments

  1. Angus McPhail Angus McPhail Australia says:

    "Besides age and sex, the algorithm is based on simple routine data that is either available to therapists or can be collected easily, such as BMI, total cholesterol, or HbA1c. In this way, people who produce less insulin or tend to exhibit insufficiently controlled "Quote
    from above "Both my Half-brother (same mother) and I became diabetic at age 45 with acute forms of ketoacidosis. My brother was deemed LADA Type 1, I was deemed Type 2
    My story is one of total ignorance by clinicians, CDE, and Path Labs on HbA1c and unreliability due to ANY form of Anemia. Over a 20-year period, A1cs of 3.8% to 4.4% were considered "great Control"??? this explains how "silent hemoglobinopathies " confound A1c. Iron, Vit B12; and Folate deficiencies (common in Women especially) and, in my case, low-grade hemolytic anemia (acquired through chemicals used in engineering)
    HbA1c should NEVER be used in isolation A fasting Glucose Reading, should always accompany an HbA1c. Pathology, NOT GPs, should compare these and alert GPs if some form of anemia is present. I have a fructosamine test. since discovering these blunders,
    In Australia we use HbA1c <6.5% no diabetes as the Diagnostic test?? which allows our C.A.L.D populations susceptible to carrier traits of Sickle cell and Thalassemia, BAME populations in the UK, and Women in General, to fall through. the net of" Not being Diagnosed or Managed Medication wise"

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Elevated TMAO levels linked to higher diabetes risk, study finds